输卵管妊娠患者的临床治疗体会

Clinical Treatment Experience in Tubal Pregnancy patients

目的：总结输卵管妊娠患者的临床治疗体会。方法选取2013年1月～2014年2月间我院收治的输卵管妊娠患者41例，观察组应用米非司酮与甲氨蝶呤联合治疗，对照组单纯应用甲氨蝶呤治疗，对比两组治疗效果与不良反应。结果经过治疗，观察组总有效率（95.65%）与对照组（83.33%）对比相对较高，不良反应（8.70%）少于对照组（27.79%），两组患者治疗效果差异显著，有统计学意义（P〈0.05）。结论米非司酮与甲氨蝶呤联合治疗输卵管妊娠能够保留女性生育功能，改善患者健康质量，效果良好，安全性高。

Objectives The clinical efficacy in treatment of tubal pregnancy patients is to be investigated.MethodsChoose 41 tubal pregnancy patients who are treated in hospital from January 2013 to February 2014. Patients in study group are given combined treatment of mifepristone and methotrexate, while patients in control group are given methotrexate treatment only, and then compare treatment efficacy and side-effect incidence in two groups.ResultsAfter treatment, the treatment efficacy in study group （95.65%） is much higher than the treatment efficacy in control group （83.33%）; while, the side-effect incidence in study group （8.70%） is much lower than side-effect incidence in control group （27.79%）; there is a treatment efficacy differential between the two groups, and such a differential has statistic value（P〈 0.05）. Conclusions Combined treatment of mifepristone and methotrexate is of efficacy to maintain female reproductive function and improve patients’ quality of health with medical safety.